2 ms·

> Frankly the US pays for the cost of the research while the rest of the world just pays for the cost of production. Top 10 pharma companies, 5/10 are US (2 UK

> Frankly the US pays for the cost of the research while the rest of the world just pays for the cost of production. Top 10 pharma companies, 5/10 are US (2 UK, 2 Swiss, 1 French). 4 of the top 6 for profit margins (from 43%(!) to 19%) are US (Merck is the only outlier, 9th, at 10%). 4 of the top 5 for Sales and Marketing Spend (both on raw dollars and as a percentage of revenue) are US. 3 of the bottom 5 for R&D spend (as a percentage of revenue) are US. Source: http://www.bbc.com/news/business-28212223 http://www.bbc.com/news/business-28212223

Wytwwww 3y ago
That's a 10 year old article. Although if we rank by market cap top 6 are from the US these days (by revenue 5 out 10 seem to be European) so not much has seemingly changed (besides Novo Nordisk becoming the second most valuable pharma company out of nowhere)
- paulmd 3y ago
  > That's a 10 year old article. Although [the] top 6 are from the US these days […] so not much has seemingly changed Well, thanks for the update. Correcting a citation an out-of-date article that is - as you admit - apparently still relevant as cited was definitely worth everyone’s time.
  - Wytwwww 3y ago
    The very specific figures from that comment are obviously not really correct. e.g. Pfizer's profit margin in 2023 was ~3.5% which isn't that great (and that's the largest pharma company by revenue).
lostlogin 3y ago
Keep in mind that marketing is a bit complicated - very few countries allow direct to consumer marketing. I think kits just the US and New Zealand. Obviously there would still be marketing in other countries, but a heavy US presence likely skews things. https://en.m.wikipedia.org/wiki/Direct-to-consumer_advertising https://en.m.wikipedia.org/wiki/Direct-to-consumer_advertisi...
- FireBeyond 3y ago
  Fun fact: the main reason it was legalized in New Zealand was heavy US pressure and lobbying over trade agreements and there’s been substantial pressure to get rid of it since then.

Wytwwww 3y ago

That's a 10 year old article. Although if we rank by market cap top 6 are from the US these days (by revenue 5 out 10 seem to be European) so not much has seemingly changed (besides Novo Nordisk becoming the second most valuable pharma company out of nowhere)

paulmd 3y ago
> That's a 10 year old article. Although [the] top 6 are from the US these days […] so not much has seemingly changed Well, thanks for the update. Correcting a citation an out-of-date article that is - as you admit - apparently still relevant as cited was definitely worth everyone’s time.
- Wytwwww 3y ago
  The very specific figures from that comment are obviously not really correct. e.g. Pfizer's profit margin in 2023 was ~3.5% which isn't that great (and that's the largest pharma company by revenue).

lostlogin 3y ago

Keep in mind that marketing is a bit complicated - very few countries allow direct to consumer marketing. I think kits just the US and New Zealand. Obviously there would still be marketing in other countries, but a heavy US presence likely skews things. https://en.m.wikipedia.org/wiki/Direct-to-consumer_advertising https://en.m.wikipedia.org/wiki/Direct-to-consumer_advertisi...

FireBeyond 3y ago
Fun fact: the main reason it was legalized in New Zealand was heavy US pressure and lobbying over trade agreements and there’s been substantial pressure to get rid of it since then.